J&J reaping benefits from device business restructuring, CEO says | Offering pulls in $3.5M for Sunshine Heart | Consensus Orthopedics obtains $1M in funding round
July 22, 2016
ADVAMED SmartBrief
News for medical technology professionals
Top Story
J&J reaping benefits from device business restructuring, CEO says
Johnson & Johnson is progressing as planned six months after implementing a restructuring process for its orthopedics, surgery and cardiovascular segments, company CEO Alex Gorsky said at an earnings call in which the company reported global device sales of $6.4 billion during the second quarter, up 0.8% from a year earlier. Gorsky added that in considering merger and acquisition opportunities, the company will be "very disciplined" and "very decisive."
Med Device Online (7/21) 
LinkedIn Twitter Facebook Google+ Email
Positive Results Yields Multiple Expansions
In an effort to regain share in a growing market, a global leader in diagnostics collaborated with SalesForce4Hire to reassess their strategy and quickly bring value into focus. Click here to learn more.
Business & Market Trends
Offering pulls in $3.5M for Sunshine Heart
A direct offering of 3,468 shares of Series B convertible preferred stock has brought in $3.5 million for Eden Prairie, Minn.-based Sunshine Heart, which makes the C-Pulse system for left ventricular load reduction using intra-aortic balloon counter-pulsation. The proceeds will be used for general corporate functions and as working capital.
MassDevice.com (Boston) (7/21) 
LinkedIn Twitter Facebook Google+ Email
Consensus Orthopedics obtains $1M in funding round
A round of equity financing has brought in $1 million for El Dorado Hills, Calif.-based Consensus Orthopedics, bringing the company closer to its $4 million goal, according to a filing with the SEC. The company did not disclose how it will use the proceeds.
The Consumer Eagle (7/21) 
LinkedIn Twitter Facebook Google+ Email
Bovie Medical, Hologic reach sales channel partnership deal
Bovie Medical's J-Plasma product line will be added to Hologic's gynecological and gynecological/oncological surgery business across three regions in the US under a sales channel partnership agreement. The companies have an option to extend the initial six-month deal into a global distribution agreement involving the full surgical sales force of Hologic.
MassDevice.com (Boston) (7/21) 
LinkedIn Twitter Facebook Google+ Email
J&J, Materialise team up on 3D-printed titanium craniofacial implants
A deal has been reached between Johnson & Johnson and Belgium-based 3D printing provider Materialise to create personalized titanium 3D craniofacial implants for patients with disorders of the face and skull; terms were undisclosed. Materialise will facilitate 3D printing of the Trumatch line of implants from J&J's DePuy Synthes unit.
MassDevice.com (Boston) (7/21) 
LinkedIn Twitter Facebook Google+ Email
Varian Medical Systems to name imaging spinoff Varex Imaging
Varian Medical Systems' Imaging Components business will be named Varex Imaging upon completion of the division's spinoff by year's end. Sunny Sanyal, president of the Imaging Components unit, will serve as CEO at Varex, which will offer software, components and services for X-ray systems.
AuntMinnie.com (free registration) (7/21) 
LinkedIn Twitter Facebook Google+ Email
Science & Health
LifeBond's Surgical Sealant Kit gets IDE from FDA
The FDA has given LifeBond an investigational device exemption to conduct a study of its LifeSeal Surgical Sealant Kit, which is designed for staple-line leakage reduction in gastrointestinal resection procedures.
FDAnews (7/22) 
LinkedIn Twitter Facebook Google+ Email
Study shows positive results for Accuray's radiation therapy system
A study in Anticancer Research: International Journal of Cancer Research and Treatment showed positive results for Accuray's TomoTherapy system. Use of the system in treating 111 women with once-daily accelerated partial-breast irradiation showed no cancer recurrence after a median of 34 months and resulted in lower toxicity, better cosmetic outcomes and minimal side effects.
AuntMinnie.com (free registration) (7/21) 
LinkedIn Twitter Facebook Google+ Email
Emerging Technologies
Multi-sinus dilation system released by Acclarent
The RELIEVA SCOUT Multi-Sinus Dilation System has been launched by Johnson & Johnson subsidiary Acclarent for use in treating patients with chronic sinusitis. The sinuplasty device widens a patient's sinus opening using a flexible balloon.
MedGadget.com (7/21) 
LinkedIn Twitter Facebook Google+ Email
Government & Regulatory
FDA panel backs new indication for Dexcom's glucose monitor
An FDA panel has voted in favor of approving Dexcom's G5 Mobile Continuous Glucose Monitoring System for use as a replacement for finger-stick testing in patients with diabetes. The panel found that the device, which is currently an adjunct to the method, is safe and effective, and its benefits outweigh the risks of use.
Medtech Insight (free-article access for SmartBrief readers) (7/21) 
LinkedIn Twitter Facebook Google+ Email
AdvaMed Events and Education
Medical Device Complaints, MDRs & Reports Workshop
Oct. 5-6 | South San Francisco, Calif.
How do you implement and measure the effectiveness of a complaint-handling system covering a diverse set of possible products and problems? How are complaint files managed across multiple domestic and international facilities? When do complaints rise to the level of MDRs, and how do you handle recalls? What are the current FDA enforcement trends in these areas? Industry experts and FDA staff (invited) will explore these issues during this day-and-a-half workshop. Learn more.
LinkedIn Twitter Facebook Google+ Email
510(K) Submissions Workshop
Oct. 31-Nov. 1 | Washington, D.C.
FDA (invited) and industry experts are coming together to teach you the basics of 510(k) submissions. You'll learn the FDA's updates to the 510(k) process, considerations for determining a product's regulatory route to market, factors to consider when planning and assembling a 510(k) submission, and tips and hints on interacting with the FDA during the 510(k) review process. Learn more.
LinkedIn Twitter Facebook Google+ Email
Learn more about AdvaMed:
About AdvaMed | Join | Courses | Events | Newsroom
powered by
Chief Compliance Officer
Clinical Site Manager
The greatest mistake you can make in life is to continually be afraid you will make one.
Elbert Hubbard,
writer and artist
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Meryl Harold
P: 202.407.7828
Jobs Contact  -  jobhelp@smartbrief.com
Editor  -  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2016 SmartBrief, Inc.®
Privacy policy |  Legal Information